BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25826114)

  • 1. The role of APOE-ɛ4 and beta amyloid in the differential rate of recovery from ECT: a review.
    Sutton TA; Sohrabi HR; Rainey-Smith SR; Bird SM; Weinborn M; Martins RN
    Transl Psychiatry; 2015 Mar; 5(3):e539. PubMed ID: 25826114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.
    Lim YY; Villemagne VL; Pietrzak RH; Ames D; Ellis KA; Harrington K; Snyder PJ; Martins RN; Masters CL; Rowe CC; Maruff P;
    Neurobiol Aging; 2015 Mar; 36(3):1239-44. PubMed ID: 25559335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E4 Mediates the Association Between Midlife Dyslipidemia and Cerebral Amyloid in Aging Women.
    Szoeke C; Goodwill AM; Gorelik A; Dennerstein L; Caeyenberghs K; Simpson S; Hill E; Campbell S
    J Alzheimers Dis; 2019; 68(1):105-114. PubMed ID: 30689578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Inter-Hemispheric Functional Connectivity in Cognitively Intact Elderly APOE ɛ4 Carriers: A Preliminary Study.
    Luo X; Qiu T; Xu X; Huang P; Gu Q; Shen Z; Yu X; Jia Y; Guan X; Song R; Zhang M;
    J Alzheimers Dis; 2016; 50(4):1137-48. PubMed ID: 26836191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults.
    Hollands S; Lim YY; Laws SM; Villemagne VL; Pietrzak RH; Harrington K; Porter T; Snyder P; Ames D; Fowler C; Rainey-Smith SR; Martins RN; Salvado O; Robertson J; Rowe CC; Masters CL; Maruff P;
    J Alzheimers Dis; 2017; 57(2):411-422. PubMed ID: 28234254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective Cognitive Decline and APOE ɛ4: A Systematic Review.
    Ali JI; Smart CM; Gawryluk JR
    J Alzheimers Dis; 2018; 65(1):303-320. PubMed ID: 30040718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
    Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aβ amyloid, cognition, and APOE genotype in healthy older adults.
    Lim YY; Ellis KA; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
    Alzheimers Dement; 2013 Sep; 9(5):538-45. PubMed ID: 23159043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease.
    Waring JF; Tang Q; Robieson WZ; King DP; Das U; Dubow J; Dutta S; Marek GJ; Gault LM
    J Alzheimers Dis; 2015; 47(1):137-48. PubMed ID: 26402762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease.
    Qiu WQ; Zhu H; Dean M; Liu Z; Vu L; Fan G; Li H; Mwamburi M; Steffens DC; Au R
    Int J Geriatr Psychiatry; 2016 Mar; 31(3):316-22. PubMed ID: 26250797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months.
    Thai C; Lim YY; Villemagne VL; Laws SM; Ames D; Ellis KA; Rainey-Smith SR; Martins RN; Masters CL; Rowe CC; Maruff P;
    PLoS One; 2015; 10(10):e0139082. PubMed ID: 26430784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.
    Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC
    Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term neurocognitive functioning after electroconvulsive therapy in depressed elderly: a prospective naturalistic study.
    Verwijk E; Comijs HC; Kok RM; Spaans HP; Tielkes CE; Scherder EJ; Stek ML
    Int Psychogeriatr; 2014 Feb; 26(2):315-24. PubMed ID: 24280446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment.
    Hanson AJ; Bayer JL; Baker LD; Cholerton B; VanFossen B; Trittschuh E; Rissman RA; Donohue MC; Moghadam SH; Plymate SR; Craft S
    J Alzheimers Dis; 2015; 48(1):205-18. PubMed ID: 26401941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
    Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
    Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Amyloid-β and Alzheimer's Disease-Related Changes in Late-Life Depression.
    Yamazaki C; Tamaoki T; Nunomura A; Tamai K; Yasuda K; Motohashi N
    J Alzheimers Dis; 2017; 58(2):349-354. PubMed ID: 28453490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing.
    Brown BM; Peiffer JJ; Taddei K; Lui JK; Laws SM; Gupta VB; Taddei T; Ward VK; Rodrigues MA; Burnham S; Rainey-Smith SR; Villemagne VL; Bush A; Ellis KA; Masters CL; Ames D; Macaulay SL; Szoeke C; Rowe CC; Martins RN
    Mol Psychiatry; 2013 Aug; 18(8):875-81. PubMed ID: 22889922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
    Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
    J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.